Fig. 2 | Scientific Reports

Fig. 2

From: Long-term efficacy of therapeutic drug monitoring-guided optimization of ustekinumab maintenance therapy for Crohn’s disease patients

Fig. 2

Long-term clinical remission for patients in TDM and non-TDM cohorts. (A) clinical remission for patients achieved clinical remission at baseline. (B) Clinical remission for patients reached endoscopic response at baseline. (C) Clinical remission for patients with mucosal healing at baseline. TDM group, patients received optimized ustekinumab maintenance treatment guided by TDM; non-TDM group, patients received routinely subcutaneous ustekinumab maintenance treatment.

Back to article page